Autres langues Xencor, Inc.

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
23,93 ^USD	+14,28%		+25,81%	+12,72%

16/04	XENCOR, INC. : BTIG reste à l'achat	ZM
09/04	Xencor nomme Bart Cornelissen au poste de directeur financier	MT

Xencor Names Bart Cornelissen as Chief Financial Officer	09/04
Xencor Appoints Bart Cornelissen as Chief Financial Officer	09/04
Xencor, Inc. Announces CFO Changes	09/04
Xencor Appoints Bart Cornelissen as Senior Vice President	09/04
USTPO Issues Means-Plus-Function Memorandum	27/03
Xencor Insider Sold Shares Worth $293,519, According to a Recent SEC Filing	07/03
North American Morning Briefing : Fed's Preferred -2-	29/02
Xencor to Present at Upcoming Investor Conferences	28/02
Xencor: Q4 Earnings Snapshot	27/02
Earnings Flash (XNCR) XENCOR Posts Q4 Revenue $44.7M, vs. Street Est of $74.7M	27/02
Xencor, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	27/02
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results	27/02
Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update	20/02
Treatment Of Antibody Claims In The U.S. After Amgen v. Sanofi	19/02
Xencor Insider Sold Shares Worth $1,048,743, According to a Recent SEC Filing	14/02
Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab	06/02
Federal Circuit Remands To USPTO To Clarify Analysis Of Jepson-Format And Means-Plus-Function Claims In The Field Of Biotechnology	05/02
Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03/01
Xencor, Inc. Appoints Dane Leone as Senior Vice President, Corporate Strategy	02/01
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy	02/01

Aucun résultat pour cette recherche